1-Hydroxybenzotriazole → 2-hydroxy-8-phenyl-N-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)octanamide
반응식
[OH:1][CH:2]([CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][C:12]1[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=1)[C:3]([OH:5])=O.C(O)(=O)C(O)=O.[C:24]1([C:30]2[O:34][C:33]([CH2:35][NH2:36])=[N:32][N:31]=2)[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1.C1C=CC2N(O)N=NC=2C=1.C(N(C(C)C)CC)(C)C.Cl.C(N=C=NCCCN(C)C)C>CN(C=O)C>[OH:1][CH:2]([CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][C:12]1[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=1)[C:3]([NH:36][CH2:35][C:33]1[O:34][C:30]([C:24]2[CH:25]=[CH:26][CH:27]=[CH:28][CH:29]=2)=[N:31][N:32]=1)=[O:5]참가 물질
7
반응물 5
생성물 1
시약·촉매·용매 1
실험 절차
To a solution of 2-hydroxy-8-phenyloctanoic acid (458 mg, 1.94 mmol), 5-phenyl-1,3,4-oxadiazol-2-yl methanamine oxalate (514 mg, 1.94 mmol), HOBt (314 mg, 2.3 mmol) and diisopropylethyl amine (501 mg, 3.9 mmol) in DMF (15 mL) was added 1-ethyl-3(3-dimethylaminopropyl) carbodiimide hydrochloride (446 mg, 2.3 mmol). The suspension was stirred for 48 h then filtered. The filtrate was diluted with EtOAc and washed sequentially with water, saturated NaHCO3, and brine. The organic phase was dried (Na2SO4) and filtered and the residue triturated with EtOAc to yield 2-hydroxy-8-phenyl-N-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)octanamide (MH+=394).
후처리
- filtrationthen filtered
- additionThe filtrate was diluted with EtOAc
- washwashed sequentially with water, saturated NaHCO3, and brine
- dry with materialThe organic phase was dried (Na2SO4)
- filtrationfiltered
- customthe residue triturated with EtOAc
출처 및 근거
- ORD 기록
- ord-58726b9c410d457bb9ef4c7b17f6a3c0
- 출처 데이터셋
- uspto-grants-2013_07
- 특허 번호
- US08476302B2
반응 노트
불러오는 중…